Search Results 391-400 of 2974 for ai合成视频的网站,ai 绘画网站中文,ai 做网站,ai网络视频,ai画画网站官网,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.saweb.com

  1. A Study to Evaluate the Impact of Nutrition Education and Access to Nutritious Foods on Diabetes Control - Mayo Clinic

    The purpose of this study is to evaluate whether or not a 6 month supply (1 meal//day) of healthy food choices readily available in the patient's home and self ...

  2. Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  3. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    The purpose of this study is to define the recommended dose, safety, tolerability, immunogenicity, and preliminary effectiveness of EO2463 during monotherapy ...

  4. A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Alumni - Genetics of Alzheimer's Disease and Endophenotypes Laboratory - Mayo Clinic Research

    Alumni of Dr. Ertekin-Taner's Genetics of Alzheimer's Disease and Endophenotypes Lab at Mayo Clinic's campus in Florida.

  6. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    The study will include a Phase 1 part to determine the recommended dose of JCARH125 in subjects with relapsed and/or refractory multiple myeloma, followed by a ...

  7. A Survey of Pheochromocytoma and Paraganglioma Patient Environment - Mayo Clinic

    The purpose of this study is to determine the association of environmental, geographic factors, as well as presence of comorbidities associated with hypoxia ...

  8. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  9. Students and scholars - Training and Education - Center for Clinical and Translational Science (CCaTS)

    All students registered in CCaTS educational programs are evaluated with regard to their overall progress, GPA and grades in individual courses. Also evaluated ...

  10. The KAPP-Sen Tissue Mapping Center Collaborative - Mayo Clinic

    About this study. The purpose of the KAPP-Sen Tissue Mapping Center (TMC) Collaborative is an effort to characterize cellular senescence (cellular aging) in ...